HSPD1 and atherosclerosis: A multivalent vaccine combining immunogenic epitopes of HSP60, ApoB-100, and β2 glycoprotein I in a chimeric protein has also been suggested as a potential candidate for modulation and reduction of atherosclerosis [21].